Dragonchain has announced its new partnership with humanitarian group M2030 in a bid to fight malaria with blockchain.
Dragonchain was originally developed at Disney’s Seattle office in 2015. In 2016, it was part of Disney’s private blockchain platform before its release as open source software under the Apache 2 license in October 2016.
M2030 is a Singapore-based humanitarian group created by Asia Pacific Leaders Malaria Alliance (APLMA). M2030’s corporate partners can use the company’s brand for awareness-raising campaigns. In return, M2030 pledges funds to fight malaria in numerous countries. Its aim is to eliminate malaria in Asia by 2030.
Dragonchain announced the new partnership in a Medium post. As M2030’s technology partner, Dragonchain will be providing blockchain-based services and the capabilities of the Dragonchain platform to help tackle malaria – starting with Vietnam.
These services and capabilities will improve the donation process and should help bring transparency to contributions, which will enable organisations and individuals to track the use of their donations.
Patrik Silborn, co-founder of M2030, commented: “We are excited to partner with Dragonchain in Vietnam. By using their services and capabilities, we can enhance the trust in M2030.”
“By working with Dragonchain, we will be able to onboard some of the best businesses in Vietnam, and ultimately end malaria once and for all,” added Gerard Toeh, co-founder of M2030.
This isn’t the first time blockchain technology has been used in the healthcare sector.
Shidan Gouran, CEO and president of investment firm Global Blockchain, believes end-to-end encryption can help remedy many issues with privacy and consent in the healthcare industry.
Interested in reading more about blockchain and healthcare? Discover five ways blockchain technology could transform the healthcare system here on Coin Rivet.
Disclaimer: The views and opinions expressed by the author should not be considered as financial advice. We do not give advice on financial products.